| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/28/2004 | US6797267 Use of cytokines and mitogens to inhibit pathological immune responses |
| 09/28/2004 | US6797265 Therapy for metabolism disorders; gene therapy |
| 09/28/2004 | US6797264 Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
| 09/28/2004 | US6797263 Compositions and methods for achieving immune suppression |
| 09/28/2004 | CA2333085C Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use |
| 09/28/2004 | CA2298414C Method for preventing and treating hearing loss using a neurturin protein product |
| 09/28/2004 | CA2177267C Agrobacterium tumefaciens transformation of musa species |
| 09/23/2004 | WO2004081533A2 Vault and vault-like carrier molecules |
| 09/23/2004 | WO2004081218A1 Gene trap system |
| 09/23/2004 | WO2004081209A1 Genes controlling plant cell wall formation |
| 09/23/2004 | WO2004081205A1 Differentiation of human embryonic stem cells to cardiomyocytes |
| 09/23/2004 | WO2004081203A1 Extraction and use of collagen extracted from either a sea mammal or a bony fish |
| 09/23/2004 | WO2004081174A2 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker |
| 09/23/2004 | WO2004081172A2 Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells |
| 09/23/2004 | WO2004081167A2 Expression vectors comprising the mcmv ie2 promoter |
| 09/23/2004 | WO2004081052A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies |
| 09/23/2004 | WO2004081041A1 Organic anion transporting (oat)-like protein ust3-like1 and uses thereof |
| 09/23/2004 | WO2004081039A1 Novel protein and its dna |
| 09/23/2004 | WO2004080394A2 Stat3 antagonists and their use as vaccines against cancer |
| 09/23/2004 | WO2004080175A2 Scaffold for cell growth and differentiation |
| 09/23/2004 | WO2004067704A3 Freeze-dried fibrin matrices and methods for preparation thereof |
| 09/23/2004 | WO2004060052A3 Transgenic mice expressing human cd20 and/or cd16 |
| 09/23/2004 | WO2004037847A3 Hiv envelope-cd4 complexes and hybrids |
| 09/23/2004 | WO2004035082A3 Proteins involved in the regulation of energy homeostasis |
| 09/23/2004 | WO2004031415A3 Methods and compositions for rapid development of screening assays nuclear receptors |
| 09/23/2004 | WO2004029137A3 Cross-linked polymer matrices, and methods of making and using same |
| 09/23/2004 | WO2004010852A3 Tissue compositions and methods for producing same |
| 09/23/2004 | WO2004009782A3 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 09/23/2004 | WO2003106621A3 Anti-igf-i receptor antibody |
| 09/23/2004 | WO2003102157A3 Synthetic antibody phage libraries |
| 09/23/2004 | WO2003100032A3 Dwarfism genes and dwarf plants |
| 09/23/2004 | WO2003086175A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/23/2004 | WO2003020956A3 Nucleid acid compositions conferring herbicide resistance |
| 09/23/2004 | WO2003011219A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 09/23/2004 | WO2003011209A8 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes |
| 09/23/2004 | WO2002101059A3 Transgenic plants synthesising high amylose starch |
| 09/23/2004 | WO2002095003A3 Phytases, nucleic acids encoding them and methods for making and using them |
| 09/23/2004 | US20040187177 Method to enhance agrobacterium-mediated transformation of plants |
| 09/23/2004 | US20040187170 Characterisation of gene function using double stranded RNA inhibition |
| 09/23/2004 | US20040186587 Devices and methods for treating tissue |
| 09/23/2004 | US20040186459 wherein inserting two nanotubes into the cell, measuring voltage and resistance between, and relating voltage and resistance to properties of the cell |
| 09/23/2004 | US20040186421 Controlled enzymatic removal and retrieval of cells |
| 09/23/2004 | US20040186051 Apo-2 ligand variants and uses thereof |
| 09/23/2004 | US20040185567 Modification of plant genomes |
| 09/23/2004 | US20040185563 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 09/23/2004 | US20040185562 Transforming cells with nucleotide sequences coding and expressing enzymatic polypeptides associated with biosynthesis of glucuronic, ascorbic and glucaric acids; bioreactors |
| 09/23/2004 | US20040185561 Animal product-free cell culture media extracts, supplements and culture media supplement systems |
| 09/23/2004 | US20040185560 Accelerated culture system for intestinal epithelial cell monolayers |
| 09/23/2004 | US20040185558 Propagating central nervous system tissue in microgravity and generating animal models for screening drugs associated with treatment of epilepsy |
| 09/23/2004 | US20040185557 Human linkeage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses |
| 09/23/2004 | US20040185546 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 09/23/2004 | US20040185541 Heterologous production of polyketides |
| 09/23/2004 | US20040185533 Corticotropin-releasing factor2 receptors |
| 09/23/2004 | US20040185524 comprises a solute and dimethylsulfoxide (DMSO) by fluid phase endocytosis to produce an internally loaded biological sample; includes freeze/vaccum drying |
| 09/23/2004 | US20040185508 Methods and reagents for modulating cholesterol levels |
| 09/23/2004 | US20040185507 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
| 09/23/2004 | US20040185503 Administering peroxisome proliferator-activated receptor agonist; assaying substance for up-regulating the expression of fatty acid-binding protein; glomerulonephritis, nephrotic syndrome, focal glomerulosclerosis |
| 09/23/2004 | US20040185468 Promoter variants of the alpha-7 nicotinic acetylcholine receptor |
| 09/23/2004 | US20040185465 for diagnosing a disease in an animal or susceptibility to a disease related to an over-expression of a phosphodiesterase; for drug screening antiinflammatory agents |
| 09/23/2004 | US20040185460 kits for drug screening by gel-shift assay, western blot, phage-based expression cloning, co-fractionation by chromatography, co-precipitation, cross linking, interaction trap/two hybrid analysis, and enzyme linked immunosorbent assay (ELISA) |
| 09/23/2004 | US20040185441 obtained from Coleoptera having a luciferin-luciferase reaction by culturing transformant/transductant; genetic engineering |
| 09/23/2004 | US20040185439 using polymorphisms to determine susceptibility cancer, osteoporosis, cardiovascular disorders; for drug screening |
| 09/23/2004 | US20040185436 chimeric immunoglobulin for detecting hepatitis c viral (HVC) infections and/or contaminated blood products; diagnosis and viral diseases; kits |
| 09/23/2004 | US20040185431 for drug screening anticancer agents using animal model expression profiles; genetic engineering |
| 09/23/2004 | US20040185429 Method for discovering neurogenic agents |
| 09/23/2004 | US20040185425 comprising submerging the tissue of the multicellular organism in an insect body fluid medium treated with heat, and drying the tissue for 48 hours or more |
| 09/23/2004 | US20040185146 Methods for producing sialyloligosaccharides in a dairy source |
| 09/23/2004 | US20040185083 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
| 09/23/2004 | US20040185048 Modulation of IL-2- and IL-15-mediated T cell responses |
| 09/23/2004 | US20040185046 Methods of treating autoimmune disease via CTLA-4Ig |
| 09/23/2004 | US20040185043 Administering agent that depletes alpha beta -, and gamma delta -TCR+ T cells and/or CD8+ T cells; transplantation with hematopoietic stem cells from donor matched at the major histocompatibility complex class I K locus; grafting |
| 09/23/2004 | US20040185034 anti-inflammatory cytokines, such as IL-4, IL-10 and chemokines, to induce development of suppressor activity in T cells |
| 09/23/2004 | US20040185033 Tumor antigens and CTL clones isolated by a novel procedure |
| 09/23/2004 | DE10312144A1 Trägermaterial für die Gewebe- und Zellkultur und die Herstellung von Implantatmaterialien Support material for tissue and cell culture and the production of implant materials |
| 09/23/2004 | DE10310261A1 Identifizierung von Antigen-Epitopen Identification of antigen epitopes |
| 09/23/2004 | CA2518907A1 Gene trap system |
| 09/23/2004 | CA2518905A1 Extraction and use of collagen extracted from either a sea mammal or a bony fish |
| 09/23/2004 | CA2518577A1 Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells |
| 09/23/2004 | CA2518549A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies |
| 09/23/2004 | CA2518508A1 Differentiation of human embryonic stem cells to cardiomyocytes |
| 09/23/2004 | CA2518182A1 Scaffold for cell growth and differentiation |
| 09/22/2004 | EP1460133A1 Nucleic acids with the aid of which plants having an altered metabolite content can be produced |
| 09/22/2004 | EP1460132A1 Antibodies with specific immunoreactivity to thyroid carcinoma cells |
| 09/22/2004 | EP1459758A1 Agents promoting the proliferation and/or differentiation of hematopoietic stem cells and/or hematopoietic precursor cells |
| 09/22/2004 | EP1459065A2 Processes for the measurement of the potency of glatiramer acetate |
| 09/22/2004 | EP1458880A1 Isolation tool for viable c-kit expressing cells |
| 09/22/2004 | EP1458879A2 Method for producing a transgenic organism using a lentiviral expression vector such as eiav |
| 09/22/2004 | EP1458874A2 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase |
| 09/22/2004 | EP1458867A2 Gene promoters |
| 09/22/2004 | EP1458865A2 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 09/22/2004 | EP1458864A1 Tgf-beta-specific covalently closed antisense molecule |
| 09/22/2004 | EP1458863A1 A system for stable expression of sirnas in mammalian cells |
| 09/22/2004 | EP1458857A1 Hxhv virus, nucleic material, peptide material and uses |
| 09/22/2004 | EP1458855A2 Method for the generation of proliferating and differentiating cell lines |
| 09/22/2004 | EP1458854A2 Cellular compositions and methods of making and using them |
| 09/22/2004 | EP1458853A2 Methods of donor specific crossmatching |
| 09/22/2004 | EP1458852A1 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
| 09/22/2004 | EP1458851A1 An avian embryo particulate biomass for the production of virus antigens |
| 09/22/2004 | EP1458849A2 Differentiation of human embryonic stem cells in avian embryos |
| 09/22/2004 | EP1458848A2 Nucleic acid nematicides |